logo
Select company
Select metric
-4069.47%Operating Cash Flow Margin
VS
Market
2
Sector
9
Industry
17
History
45
$ 0.24Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -44.52M-4069.47%$ 1.09M
3/31/2025$ -54.03M-3667.96%$ 1.47M
12/31/2024$ -57.02M-4125.69%$ 1.38M
9/30/2024$ -53.79M-3370.55%$ 1.6M
6/30/2024$ -59.48M-3615.81%$ 1.65M
3/31/2024$ -54.8M-4102.1%$ 1.34M
12/31/2023$ -53.64M-2776.24%$ 1.93M
9/30/2023$ -45.53M-2184.64%$ 2.08M
6/30/2023$ -47.73M-2533.28%$ 1.88M
3/31/2023$ -51.05M-2363.29%$ 2.16M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -1653.89%.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average OCF % has been -3258.32%.
  • The median OCF % for NORTHWEST BIOTHERAPEUTICS INC during this period was -3311.37%
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest OCF % over the past 5 years at -1653.89%.
  • The lowest OCF % recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe -5080.29%

NORTHWEST BIOTHERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
RNAC : CARTESIAN THERAPEUTICS INC -3307.99%INBX : INHIBRX BIOSCIENCES INC -9989.21%HUMA : HUMACYTE INC -12774.82%ABEO : ABEONA THERAPEUTICS INC -16494.75%MREO : MEREO BIOPHARMA GROUP PLC -6583.8%SEPN : SEPTERNA INC -11212.4%CRDF : CARDIFF ONCOLOGY INC -7663.92%CATX : PERSPECTIVE THERAPEUTICS INC -5244.94%BTAI : BIOXCEL THERAPEUTICS INC -6424.54%ADVM : ADVERUM BIOTECHNOLOGIES INC -13091.1%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -27.87M ] / Revenues [ $ 1.69M ]
(=) OCF % [ -1653.89% ]

NWBO - Operating Cash Flow Margin, Last 5 years

-5080.29%

Minimum

Sep 30, 2022

-1653.89%

Maximum

Sep 30, 2020

-3258.32%

Average

-3311.37%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.33% with a standard deviation of 21.12%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.33%
median12.67%
std21.12%